Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode™ Whole Transcriptome ...
BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study in collaboration with The University of Texas MD Anderson Cancer Center, ...
While RNA sequencing (RNA-seq) has become a standard tool for profiling which genes are active in an organism, determining ...
A collaboration between Karolinska Institutet, Karolinska University Hospital, and SciLifeLab has integrated whole genome sequencing into routine diagnostic investigations for rare diseases at ...
A collaboration between Karolinska Institutet, Karolinska University Hospital, and SciLifeLab has integrated whole genome sequencing into routine diagnostic investigations for rare diseases at ...
Madras Diabetes Research Foundation and Premas Life Sciences collaborate to enhance genomics research for improved diabetes ...
New research indicates that a greater number of women could benefit from targeted therapies for breast and ovarian cancer, following a landmark study that mapped mutations within tumours. Experts from ...
Neanderthals split into distinct regional groups that developed genetic differences far sooner than modern human populations typically did, according to a study published in Proceedings of the ...
Gruner looks back on 100 years of engineering expertise in the water and energy sector. The hydropower and dam engineering know‑how – historically bundled under Gruner Stucky – today forms a central ...
Sam Altman highlighted Paul Conyngham’s use of AI tools to design a cancer treatment for his dog Rosie, showing how AI can ...
Botstein, Princeton’s Anthony B. Evnin ‘62 Professor of Genomics, Emeritus, and an emeritus professor of molecular biology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results